News

PDRN injections vs PDRN skincare UK: why the confusion?

PDRN and polynucleotides have become widely discussed online, often under the nickname “salmon DNA”. Viral posts can make topical PDRN serums and creams sound like they do the same job as in-clinic injectable polynucleotides.

In reality, topical products and injectable treatments are not equivalent. They differ in delivery depth, likely biological effect, regulation, and realistic outcomes, particularly for concerns like under-eye crepiness, uneven texture, and early laxity.

This guide explains what PDRN is, how it relates to polynucleotides, what each option may help with, and how to avoid misinformation and unsafe providers.

What are PDRN and polynucleotides?

### PDRN in simple terms
PDRN stands for polydeoxyribonucleotide. It is a mixture of DNA fragments (nucleotides) that can be derived from fish sources. In aesthetic medicine, the interest is in how these fragments may support skin recovery and overall skin quality through signalling pathways involved in repair.

Polynucleotides vs PDRN

You will see both terms used online, sometimes interchangeably.

• Polynucleotides is an umbrella term for DNA fragments used for skin regeneration-style treatments.
• PDRN is a type or subset within that family, depending on how the product is manufactured and described.

Because naming varies by brand and country, it is reasonable to ask a clinic exactly what product is being used, what it contains, and what evidence supports the intended use.

Why “salmon DNA” is shorthand

“Salmon DNA” is a social media-friendly phrase that usually refers to fish-derived polynucleotides or PDRN. It is not a medical term and it can be misleading, because:

• The source does not tell you the quality, purification, or safety controls.
• “DNA” implies something dramatic, but these are processed fragments, not whole genetic material being integrated into your cells.

Topical PDRN skincare vs injectable polynucleotides

### The key difference is delivery depth
The biggest practical difference is how much active ingredient can reach the intended target.

• Topical PDRN skincare sits on the skin surface. Some ingredients can penetrate the outer barrier to a limited degree, especially with certain formulations, but penetration to the deeper dermis where structural change occurs is typically limited.
• Injectable polynucleotides are placed into specific skin layers by a trained medical professional. This direct placement is why injections are generally chosen when the goal is a measurable improvement in skin quality rather than surface hydration alone.

What each is realistically aiming to do

Topical PDRN products are usually positioned to support:

• hydration and comfort
• barrier support
• reduced appearance of dryness-related texture
• post-procedure soothing (depending on formulation)

Injectable polynucleotides are usually positioned to support:

• skin quality improvements over time (texture, fine lines, crepiness)
• improved appearance of under-eye skin quality (where appropriate)
• overall skin resilience and recovery after stressors

It is important to understand that injectable polynucleotides are not dermal filler. They do not “fill” hollows in the same way. They are typically used as a skin quality treatment, sometimes alongside other options depending on the concern.

Can viral PDRN skincare replace injections?

For most people, no. It can be a helpful supportive product, but it is unlikely to replicate the outcomes of a correctly delivered injectable course.

Topical PDRN may make the skin look better because it improves hydration and reduces dryness-related roughness. This can be very worthwhile, especially for sensitive or compromised skin. However, when the concern is crepey under-eye skin, etched fine lines, or persistent texture changes, injections tend to be the in-clinic option considered because the treatment is delivered where it can potentially influence deeper repair processes.

That said, not everyone needs injections. If your main issue is dryness, irritation, or barrier disruption, a well-formulated skincare routine may be the more sensible first step.

Best indications: who should choose which?

### Under-eyes
The under-eye area is thin and reactive, so treatment choice matters.

Topical PDRN skincare may suit:

• mild dryness and dehydration lines
• sensitivity after environmental stress
• supportive care alongside sunscreen and gentle retinoid use (if tolerated)

Injectable polynucleotides may suit:

• crepey texture and early fine lines where skin quality is the main issue
• patients seeking subtle, progressive improvement rather than volume change

What injections will not do under the eyes:

• they will not reliably correct true volume loss or significant tear trough hollowing on their own
• they will not remove pigment-related dark circles (which may be vascular, structural, or pigmentary)

A careful assessment is essential, because the under-eye area is also where poor technique and unsuitable candidates can experience prolonged swelling or dissatisfaction.

Texture, enlarged pores, and “tired” skin

Topical PDRN skincare may help:

• dryness-associated roughness
• transient irritation and barrier disruption
• improving comfort when using other actives

Injectable polynucleotides may help:

• general skin quality and texture when used as a course
• fine lines and mild crepiness across cheeks, neck, or peri-oral areas

Many patients do best with a combined approach: injections for longer-term skin quality, and skincare for ongoing barrier support.

Crepey skin on face, neck, and hands

Crepey skin often reflects a mix of dehydration, reduced elasticity, and collagen changes.

Topical PDRN skincare may help:

• dehydration and tight-feeling skin
• improving the look of superficial fine lines through moisturisation

Injectable polynucleotides may help:

• gradual improvements in the appearance of crepiness, especially when combined with a good skincare routine and sun protection

If crepiness is driven by significant laxity, other treatments may be more appropriate, and a clinician should discuss alternatives.

Barrier support and post-procedure recovery

Topical products are usually the first choice for barrier support.

Topical PDRN skincare may be used:

• after professional treatments if the product is appropriate and your clinician agrees
• during periods of sensitivity when strong actives are paused

Injectable polynucleotides may be used:

• as part of a broader plan to improve skin resilience, depending on your goals and medical suitability

Always follow your provider’s aftercare guidance, particularly after procedures that temporarily disrupt the skin barrier.

What results are realistic, and how long do they take?

### Topical PDRN skincare: timeline and expectations
What you may notice:

• within days: improved hydration, comfort, reduced tightness
• within 2 to 6 weeks: smoother-looking texture if dryness was the main driver

Limitations:

• topical PDRN is unlikely to significantly change deeper crepiness, laxity, or under-eye structural issues
• results depend heavily on the full formula, not just the presence of “PDRN” on the label

Injectable polynucleotides: timeline and expectations

Most protocols are delivered as a course (often several sessions), then maintained as advised. Your clinician should explain the plan for your skin and the product used.

What you may notice:

• within 2 to 4 weeks: early improvement in skin “bounce” and texture in some patients
• within 6 to 12 weeks: more noticeable improvements in overall skin quality and crepey appearance
• ongoing: maintenance may be needed, especially with sun exposure, smoking, or strong ongoing collagen loss

Limitations:

• they do not replace surgical tightening for significant laxity
• they do not reliably treat all causes of dark circles
• they do not provide the same effect as dermal filler for volume loss

A quick comparison table

Feature	Topical PDRN skincare	Injectable polynucleotides
Delivery depth	Surface and limited penetration	Targeted placement into specific skin layers
Best for	Hydration, barrier support, mild dryness lines	Skin quality, texture, fine lines, crepiness
Under-eye role	Supportive, mild dehydration	Can help crepey skin quality in suitable patients
Speed of visible change	Often faster (hydration effect)	Slower, progressive (course-based)
Main limitation	Cannot reliably replicate injection outcomes	Not a filler, not a lift, not a pigment treatment

Safety in the UK: avoiding misinformation and unsafe providers

### Choose qualified medical professionals
In the UK, injectable aesthetic treatments should be delivered by appropriately trained, insured medical professionals. Be cautious with:

• bargain pricing and pressure to book quickly
• vague claims like “works like filler” or “guaranteed results”
• providers unwilling to discuss product names, risks, or aftercare

Ask about product transparency

A reputable clinic should be able to tell you:

• the exact product name and manufacturer
• what the product contains and how it is intended to be used
• expected number of sessions and total cost
• possible side effects and how complications are managed

Understand contraindications and precautions

A proper consultation should cover medical history, medications, allergies, and skin examination. Treatment may be deferred or avoided in some situations, including:

• pregnancy or breastfeeding
• active skin infection or significant inflammation in the area
• certain autoimmune conditions or immune-suppressing medications, depending on individual risk
• bleeding disorders or use of medicines that increase bruising risk, where relevant

Your clinician should also discuss realistic outcomes for your specific concern, especially for the under-eye area.

Common side effects and aftercare expectations

With injections, common temporary effects can include:

• redness, swelling, tenderness
• small bruises
• small lumps at injection points that settle

Aftercare varies by clinic and product, but typically includes avoiding strenuous exercise, heat exposure, and alcohol for a short period if advised, and monitoring for unusual pain, increasing swelling, or signs of infection.

How to use skincare and injections together

A sensible, evidence-led approach often looks like this:

• establish a consistent routine: gentle cleanser, moisturiser, daily SPF
• add targeted actives as tolerated, such as retinoids, vitamin C, or barrier-supporting ingredients
• consider topical PDRN as a supportive product if your skin is dry, sensitive, or recovering
• consider injectable polynucleotides if your goal is progressive improvement in texture and crepey appearance, and you are medically suitable

The bottom line

When comparing PDRN injections vs PDRN skincare UK, the difference is mainly about delivery and realistic outcomes. Topical PDRN can be a helpful supportive skincare step for hydration and barrier comfort. Injectable polynucleotides are more likely to deliver meaningful, progressive improvements in skin quality for suitable patients, particularly for crepey texture and fine lines, including in carefully selected under-eye cases.

If you are unsure which route fits your skin and goals, you can be assessed by experienced medical professionals at Renovatio Clinic, and, if appropriate, discuss a treatment plan and aftercare. If you would like to proceed, please contact us.